
The mRNA technology from COVID-19 vaccines may help amplify cancer treatments that use the body’s own immune system to fight cancer, a new study has found.
Cancer patients who received an mRNA-based jab, for example, those made by Pfizer or Moderna, within 100 days of starting immunotherapy fared much better than those who were not vaccinated.